Compare TOI & ABAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOI | ABAT |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | 641 | N/A |
| Industry | Medical/Nursing Services | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.9M | 517.0M |
| IPO Year | N/A | 2013 |
| Metric | TOI | ABAT |
|---|---|---|
| Price | $5.28 | $3.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $6.67 | $6.00 |
| AVG Volume (30 Days) | 1.8M | ★ 8.6M |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.15 | $145.40 |
| Revenue Next Year | $25.77 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.02 | $1.20 |
| 52 Week High | $5.58 | $11.49 |
| Indicator | TOI | ABAT |
|---|---|---|
| Relative Strength Index (RSI) | 64.36 | 44.49 |
| Support Level | $2.91 | $3.08 |
| Resistance Level | $5.58 | $3.67 |
| Average True Range (ATR) | 0.40 | 0.39 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 77.49 | 5.69 |
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.